Sign In
Buy BAX
$18.54
-0.140 (-0.749%)
At Close: Jun 03, 2026
Baxter International (BAX) Misses Q2 Earnings and Revenue Estimates
01:21pm, Thursday, 31'st Jul 2025
Baxter International (BAX) came out with quarterly earnings of $0.59 per share, missing the Zacks Consensus Estimate of $0.6 per share. This compares to earnings of $0.68 per share a year ago.
BAX Stock Falls Following Q2 Earnings & Sales Miss, '25 EPS View Down
12:41pm, Thursday, 31'st Jul 2025
Baxter misses on Q2 earnings and sales, trims full-year EPS view, and posts weaker gross margin. Shares slide nearly 9% pre-market.
Baxter International Inc. (BAX) Q2 2025 Earnings Call Transcript
12:21pm, Thursday, 31'st Jul 2025
Baxter International Inc. (NYSE:BAX ) Q2 2025 Earnings Conference Call July 31, 2025 8:30 AM ET Company Participants Clare Trachtman - Vice President of Investor Relations David Brent Shafer - Chair &
Baxter (BAX) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
10:31am, Thursday, 31'st Jul 2025
While the top- and bottom-line numbers for Baxter (BAX) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to W
Baxter cuts forecast, misses estimates amid lingering hurricane impact on medical products unit
09:32am, Thursday, 31'st Jul 2025
Baxter International cut its 2025 profit forecast on Thursday, while quarterly earnings missed analysts' estimates due to the lingering effect of Hurricane Helene, which damaged a key manufacturing fa
Baxter Reports Second-Quarter 2025 Results
07:15am, Thursday, 31'st Jul 2025
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the second quarter of 2025. “For the second quarter of 2025, Baxter delive
Stay Ahead of the Game With Baxter (BAX) Q2 Earnings: Wall Street's Insights on Key Metrics
10:15am, Wednesday, 30'th Jul 2025
Besides Wall Street's top-and-bottom-line estimates for Baxter (BAX), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quart
Baxter Q2 Preview: Can Core Segments Deliver Another Solid Quarter?
01:46pm, Monday, 28'th Jul 2025
BAX aims for modest Q2 growth as core segments build on Q1 momentum and margin gains stabilize after recent recovery.
Vizient Reserve Program Expands Supply Assurance to Include IV Fluids in Collaboration With Baxter
06:00am, Wednesday, 23'rd Jul 2025
IRVING, Texas--(BUSINESS WIRE)--Vizient announced today the expansion of the Vizient Reserve Program to include IV fluids through a strategic partnership with Baxter.
Baxter the Brave Mouse Unites Baxterville Against the Cat Pack
11:00am, Tuesday, 22'nd Jul 2025
Baxter, a brave mouse from Baxterville, faces the Cat Pack's mischief in a heartwarming tale of friendship and forgiveness from Palmetto Publishing. Baxter, a brave mouse from Baxterville, faces the C
Baxter to Host Second-Quarter 2025 Financial Results Conference Call for Investors
04:15pm, Thursday, 17'th Jul 2025
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, will host a conference call to discuss its second-quarter 2025 financial results on Thursday, July 31,
Baxter Declares Quarterly Dividend
04:40pm, Monday, 14'th Jul 2025
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced that its Board of Directors has declared a quarterly cash dividend of $0.17 per share o
Medical Equipment Maker Baxter International Names New CEO
03:40pm, Monday, 07'th Jul 2025
Baxter International on Monday named Andrew Hider, chief executive of Canadian automation solutions firm ATS Corp., its new CEO.
Baxter International Names Andrew Hider as CEO
08:44am, Monday, 07'th Jul 2025
Baxter International said on Monday that Andrew Hider will take over as the medical device maker's new Chief Executive Officer.
Baxter Appoints Andrew Hider Chief Executive Officer
08:35am, Monday, 07'th Jul 2025
DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a global medtech leader, today announced the appointment of Andrew Hider as president and chief executive officer (CEO), and a m
